枸橼酸铁铵

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 枸橼酸铁铵
• 英文名称: azanium;3-carboxy-3,5-dihydroxy-5-oxopentanoate;iron
• 化学式: C6H11FeNO7
• 分子量: 265.0
• InChiKey: PLKYGPRDCKGEJH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.09
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  133
• 氢给体数：
  5
• 氢受体数：
  8

ADMET

毒理性

• 副作用

职业性肝毒素 - 第二性肝毒素：在职业环境中的毒性效应潜力是基于人类摄入或动物实验的中毒病例。

Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

毒理性

• 相互作用

当前研究调查了褪黑素是否能够改变在皮质内注射1.0微升1.0毫摩尔/升柠檬酸铁铵（FAC）或0.9%生理盐水后24小时内死亡的神经元的比例。接受褪黑素系统输注（5毫克/千克体重/天）的大鼠在FAC引起的神经元死亡比例上显示了40%的减少（P=0.019）。相比之下，通过持续光照降低内源性褪黑素并没有显著影响神经细胞死亡的程度。此外，提高或降低褪黑素水平也没有改变由生理盐水注射导致的神经元死亡数量。

...The present study has investigated whether melatonin can alter the proportion of neurons that die in the 24 hr period following 1.0 microL intracortical injections of 1.0 mM ferric ammonium citrate (FAC) or 0.9% saline. Rats which received systemic infusions of melatonin (5 mg/kg bw/day) displayed a 40% reduction (P=0.019) in the proportion of neurons killed by FAC. By contrast, reduction of endogenous melatonin by continuous light exposure did not significantly affect the extent of neuronal death. Furthermore, elevated or reduced melatonin levels did not alter the number of neurons killed by saline injections.

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 相互作用

无特定病原体的雄性Fischer-344大鼠每天接受40毫克/千克体重的柠檬酸铁铵（FAC）腹腔注射，剂量为1毫升/千克，或等体积的生理盐水。从第四天开始，大鼠通过仅鼻腔吸入的方式，每天暴露于硫酸铍（BeSO4）气溶胶2小时。到第15天，接受BeSO4加生理盐水组的死亡率达到80%，而接受BeSO4加FAC组的死亡率为33%。随后停止暴露。到第18天，BeSO4加生理盐水组的大鼠全部死亡，而BeSO4加FAC组的累计死亡率为66%。到第19天，该组的死亡率达到了最大值，为76%。

...Specific pathogen free male Fischer-344-rats received daily intraperitoneal injections of ferric-ammonium-citrate (FAC) at 40 mg/kg bw at 1 mL/kg or an equal volume of saline. Beginning on day four, rats were simultaneously exposed to an aerosol of beryllium-sulfate (BeSO4) for 2 hr/day through nose only inhalation. By day 15, mortality was 80% in the BeSO4 plus saline group as compared to 33% in the BeSO4 plus FAC group. Exposure was then discontinued. By day 18, all rats in the BeSO4 plus saline group had died, while the cumulative mortality for the BeSO4 plus FAC group was only 66%. By day 19, mortality in this group had reached a maximum of 76%.

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 相互作用

老年斑是阿尔茨海默病（AD）的主要神经病理学病变，主要由淀粉样-β肽组成，并含有高浓度的铁（1.0 mM）。/之前的研究/表明，向成年大鼠皮层内注射1.0 mM铁比对照组的生理盐水注射会导致显著的神经元损失，而注射淀粉样-β则不会。因为铁已被证明可以增加淀粉样-β的体外毒性，所以本研究旨在确定铁是否可以使淀粉样-β在体内具有神经毒性。/淀粉样-β/和1.0 mM铁（作为柠檬酸铁铵）一起注射到大鼠大脑皮层，神经元损失与纯/淀粉样-β/或纯铁产生的损失进行了比较。比较了人类和大鼠的/淀粉样-β/1-42变体，以确定它们与铁结合时是否产生相同数量的神经元损失。与/淀粉样-β/肽单独注射相比，铁与/淀粉样-β/变体共同注射导致显著的神经元损失增加，这表明铁可能有助于老年斑相关的毒性。与铁单独注射相比，大鼠/淀粉样-β/1-42与铁结合的毒性相同，而与人类/淀粉样-β/1-42结合的铁的毒性显著降低。

Senile plaques, the major neuropathological lesions of Alzheimer's disease (AD), are composed primarily of amyloid-beta ... peptide and contain high concentrations of iron (1.0 mM). /It was/ previously shown that intracortical injections of 1.0 mM iron to adult rats produce significantly more neuronal loss than control injections of saline vehicle, whereas injections of /amyloid-beta/ do not. Because iron has been shown to increase the in vitro toxicity of /amyloid-beta/, the present study was undertaken to determine whether iron can make /amyloid-beta/ neurotoxic in vivo. /Amyloid-beta/ and 1.0 mM iron (as ferric ammonium citrate) were coinjected into rat cerebral cortex, and the neuronal loss was compared with that produced by pure /amyloid-beta/ or pure iron. The human and rat variants of /amyloid-beta/1-42 were compared to determine whether they produce the same amount of neuronal loss when combined with iron. Coinjection of iron with either /amyloid-beta/ variant caused significantly more neuronal loss than /amyloid-beta/ peptide alone, suggesting that iron may contribute to the toxicity associated with senile plaques. Rat /amyloid-beta/1-42 combined with iron was as toxic as iron alone, whereas iron combined with human /amyloid-beta/1-42 was significantly less toxic.

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 解毒与急救

处理接触：摄入：给予大量水。眼睛或皮肤：用水冲洗。

Treatment of Exposure: Ingestion: give large amount of water. Eyes or skin: flush with water.

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

人体对铁的吸收和内源性排泄通过监测稳定铁同位素（58Fe）的粪便排泄进行了研究。研究在12名健康志愿者中进行，他们被分成两组。第一组作为对照组，接受了相当于6毫克铁的58Fe标记的三价铁柠檬酸铵（III）（58FeAC），第二组接受了500毫克维生素C和58FeAC的联合使用。使用了一个新的公式来计算反映肠道细胞中铁池的58Fe吸收率，并将其与Janghorbani公式得到的比率进行了比较，后者一直是常用的方法之一。结果显示，使用Janghorbani公式，第二组的58Fe吸收率在统计学上显著高于第一组（34.4 +/- 6.1% 对 15.0 +/- 5.5%，平均值 +/- 标准差）。我们的新公式也得到了类似的吸收率（34.1 +/- 6.0% 对 14.8 +/- 5.5%）。我们的结果证实了先前的发现，即铁的可用性可以通过补充维生素C来刺激。两个公式在铁的吸收上是一致的，表明肠道中由脱落的细胞引起的铁的内源性排泄并不会掩盖铁的吸收。

The absorption and endogenous excretion of iron in man was studied by monitoring the fecal excretion of a stable iron isotope (58Fe). The study was carried out for 12 healthy volunteers who were divided into two groups. Group I received 58Fe-labeled ferric ammonium citrate (III) (58FeAC) equivalent to 6 mg of iron as a control, and group II received a combination of 500 mg of vitamin C and 58FeAC. A new formula was used to calculate the 58Fe absorption ratio reflecting the pool of iron in the intestinal cells, and the ratio was compared with that obtained from Janghorbani's formula, which has been used as one of the common methods. As a result, the 58Fe absorption ratio in group II was statistically significantly higher than that of group I (34.4 +/- 6.1% vs. 15.0 +/- 5.5%, M +/- SD) using Janghorbani's formula. The similar absorption ratio (34.1 +/- 6.0% vs. 14.8 +/- 5.5%) was also obtained by our new formula. Our results confirmed the previous findings that the availability of iron is stimulated by the supplementation of vitamin C. Both formulae agreed in the absorption of iron, indicating that the endogenous excretion of iron (caused by the desquamated cells) in the intestine does not disguise the iron absorption.

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

评估了一种商业品牌的小颗粒还原铁在10名正常受试者中的吸收情况。对于每位受试者，使用血红蛋白结合法来测量从硫酸亚铁或柠檬酸铁铵中吸收60毫克铁的真实吸收量。铁耐量测试（ITT）也针对这两种化合物和还原铁进行了研究。此过程包括在6小时内特定时间测量血浆铁升高的曲线下面积，或者通过测量缓慢静脉注射0.4毫克铁（作为柠檬酸铁）后4小时内特定时间的血浆铁消失率来校正的血浆铁峰值。仅使用ITT来测量60毫克还原铁的吸收。在每位受试者中测量了参考剂量铁抗坏血酸的吸收。将柠檬酸铁铵和还原铁的吸收量表示为剂量的百分比，也作为与硫酸亚铁吸收量的百分比。参考剂量、FeSO4和柠檬酸铁铵的平均几何“真实吸收百分比”分别为39.0、10.4和2.4。后者是FeSO4的23%。通过ITT，FeSO4、柠檬酸铁铵和还原铁的平均几何吸收百分比分别为7.9、3.7和3.2，或者分别是FeSO4的47%和41%。我们建议，测试的商业品牌还原铁的真实吸收量是基于还原铁ITT结果与柠檬酸铁铵ITT和真实吸收量与FeSO4的关系，是FeSO4的20%。

The absorption of a commercial brand of small-particle reduced iron was evaluated in 10 normal subjects. For each subject, the hemoglobin incorporation method was used to measure the true absorption of 60 mg of iron from either ferrous sulfate or ferric ammonium citrate. The iron tolerance test (ITT) was also studied for these two compounds and for reduced iron. This procedure consisted of measuring the area under the curve of plasma iron elevations at specified times for 6 hours, or the peak plasma iron, corrected by the plasma iron disappearance rate obtained from measuring plasma iron at specified times for 4 hours after the slow intravenous injection of 0.4 mg of iron as ferric citrate. Only the ITT was used to measure the absorption of 60 mg of reduced iron. Reference dose iron ascorbate absorption was measured in each subject. The absorption of ferric ammonium citrate and reduced iron was expressed as percent of dose and also as absorption percent of that of ferrous sulfate. Mean % geometric "true absorptions" were 39.0 for reference dose, 10.4 for FeSO4 and 2.4 for ferric ammonium citrate. The later was 23% that of FeSO4. By ITT the mean geometric % absorptions were 7.9, 3.7 and 3.2 for FeSO4, ferric ammonium citrate and reduced iron respectively, or 47 and 41% of that of FeSO4. We propose that the true absorption of the commercial brand of reduced iron tested was 20% that of FeSO4 based on the relation between the ITT results of reduced iron and the ITT and true absorption values of ferric ammonium citrate in relation to FeSO4.

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

人体对铁的吸收和内源性排泄通过监测稳定铁同位素（58Fe）的粪便排泄进行了研究。研究在12名健康志愿者中进行，他们被分成两组。第一组作为对照组，接受了相当于6毫克铁的58Fe标记的三价铁柠檬酸铵（III）（58FeAC），第二组接受了500毫克维生素C和58FeAC的联合使用。使用了一个新的公式来计算反映肠道细胞中铁池的58Fe吸收率，并将该比率与Janghorbani公式获得的比率进行了比较，后者已被用作常见方法之一。结果显示，使用Janghorbani公式，第二组的58Fe吸收率统计学上显著高于第一组（34.4 +/- 6.1% 对 15.0 +/- 5.5%，平均值 +/- 标准差）。我们的新公式也得到了类似的吸收率（34.1 +/- 6.0% 对 14.8 +/- 5.5%）。我们的结果证实了之前的发现，即铁的可用性可以通过补充维生素C来刺激。两个公式在铁的吸收上是一致的，表明肠道中由脱落的细胞引起的铁的内源性排泄并不会掩盖铁的吸收。

The absorption and endogenous excretion of iron in man was studied by monitoring the fecal excretion of a stable iron isotope (58Fe). The study was carried out for 12 healthy volunteers who were divided into two groups. Group I received 58Fe-labeled ferric ammonium citrate (III) (58FeAC) equivalent to 6 mg of iron as a control, and group II received a combination of 500 mg of vitamin C and 58FeAC. A new formula was used to calculate the 58Fe absorption ratio reflecting the pool of iron in the intestinal cells, and the ratio was compared with that obtained from Janghorbani's formula, which has been used as one of the common methods. As a result, the 58Fe absorption ratio in group II was statistically significantly higher than that of group I (34.4 +/- 6.1% vs. 15.0 +/- 5.5%, M +/- SD) using Janghorbani's formula. The similar absorption ratio (34.1 +/- 6.0% vs. 14.8 +/- 5.5%) was also obtained by our new formula. Our results confirmed the previous findings that the availability of iron is stimulated by the supplementation of vitamin C. Both formulae agreed in the absorption of iron, indicating that the endogenous excretion of iron (caused by the desquamated cells) in the intestine does not disguise the iron absorption.

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

评估了一种商业品牌的小颗粒还原铁在10名正常受试者中的吸收情况。对于每位受试者，使用血红蛋白结合法来测量从硫酸亚铁或柠檬酸亚铁中吸收60毫克铁的真实吸收量。铁耐量测试（ITT）也用于研究这两种化合物以及还原铁。此过程包括在6小时内特定时间测量血浆铁升高的曲线下面积，或者通过测量缓慢静脉注射0.4毫克铁（作为柠檬酸铁）后4小时内特定时间的血浆铁消失速率来校正的血浆铁峰值。仅使用ITT来测量60毫克还原铁的吸收。在每位受试者中测量了参考剂量铁抗坏血酸的吸收。将柠檬酸亚铁和还原铁的吸收量表示为剂量的百分比，也作为相对于硫酸亚铁的吸收百分比。参考剂量、FeSO4和柠檬酸亚铁的平均几何“真实吸收百分比”分别为39.0、10.4和2.4。后者是FeSO4的23%。通过ITT，FeSO4、柠檬酸亚铁和还原铁的平均几何吸收百分比分别为7.9、3.7和3.2，或者分别是FeSO4的47%和41%。我们建议，测试的商业品牌还原铁的真实吸收量是基于还原铁的ITT结果与柠檬酸亚铁相对于FeSO4的ITT和真实吸收值之间的关系，是FeSO4的20%。

The absorption of a commercial brand of small-particle reduced iron was evaluated in 10 normal subjects. For each subject, the hemoglobin incorporation method was used to measure the true absorption of 60 mg of iron from either ferrous sulfate or ferric ammonium citrate. The iron tolerance test (ITT) was also studied for these two compounds and for reduced iron. This procedure consisted of measuring the area under the curve of plasma iron elevations at specified times for 6 hours, or the peak plasma iron, corrected by the plasma iron disappearance rate obtained from measuring plasma iron at specified times for 4 hours after the slow intravenous injection of 0.4 mg of iron as ferric citrate. Only the ITT was used to measure the absorption of 60 mg of reduced iron. Reference dose iron ascorbate absorption was measured in each subject. The absorption of ferric ammonium citrate and reduced iron was expressed as percent of dose and also as absorption percent of that of ferrous sulfate. Mean % geometric "true absorptions" were 39.0 for reference dose, 10.4 for FeSO4 and 2.4 for ferric ammonium citrate. The later was 23% that of FeSO4. By ITT the mean geometric % absorptions were 7.9, 3.7 and 3.2 for FeSO4, ferric ammonium citrate and reduced iron respectively, or 47 and 41% of that of FeSO4. We propose that the true absorption of the commercial brand of reduced iron tested was 20% that of FeSO4 based on the relation between the ITT results of reduced iron and the ITT and true absorption values of ferric ammonium citrate in relation to FeSO4.

来源:Hazardous Substances Data Bank (HSDB)